Description
RIMONABANT SHOULD NOT BE USED BY PEOPLE SUFFERING FROM DEPRESSION.
Rimonabant is an effectual oral prescription weight loss drug. It is presently available in the UK, Germany, and France among other countries. It awaits its FDA approval for launch in the US weight loss market.
It works by hindering the functioning of the CB-1 receptors, which are located in Endo-Cannabinoid system. When these receptors are blocked, it results in the decrease of our normal appetite. This in turn causes weight loss
|